276 related articles for article (PubMed ID: 23741072)
1. Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers.
Prosniak M; Harshyne LA; Andrews DW; Kenyon LC; Bedelbaeva K; Apanasovich TV; Heber-Katz E; Curtis MT; Cotzia P; Hooper DC
Clin Cancer Res; 2013 Jul; 19(14):3776-86. PubMed ID: 23741072
[TBL] [Abstract][Full Text] [Related]
2. Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade.
Zhu C; Kros JM; van der Weiden M; Zheng P; Cheng C; Mustafa DA
Acta Neuropathol Commun; 2017 Jan; 5(1):4. PubMed ID: 28073370
[TBL] [Abstract][Full Text] [Related]
3. Expression and release of CD14 in astrocytic brain tumors.
Deininger MH; Meyermann R; Schluesener HJ
Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
[TBL] [Abstract][Full Text] [Related]
4. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity.
Vidyarthi A; Agnihotri T; Khan N; Singh S; Tewari MK; Radotra BD; Chatterjee D; Agrewala JN
Cancer Immunol Immunother; 2019 Dec; 68(12):1995-2004. PubMed ID: 31690954
[TBL] [Abstract][Full Text] [Related]
5. The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas.
Locatelli M; Ferrero S; Martinelli Boneschi F; Boiocchi L; Zavanone M; Maria Gaini S; Bello L; Valentino S; Barbati E; Nebuloni M; Mantovani A; Garlanda C
J Neuroimmunol; 2013 Jul; 260(1-2):99-106. PubMed ID: 23664694
[TBL] [Abstract][Full Text] [Related]
6. Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma.
Lisi L; Ciotti GM; Braun D; Kalinin S; Currò D; Dello Russo C; Coli A; Mangiola A; Anile C; Feinstein DL; Navarra P
Neurosci Lett; 2017 Apr; 645():106-112. PubMed ID: 28259657
[TBL] [Abstract][Full Text] [Related]
7. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.
Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT
J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411
[TBL] [Abstract][Full Text] [Related]
8. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.
Komohara Y; Ohnishi K; Kuratsu J; Takeya M
J Pathol; 2008 Sep; 216(1):15-24. PubMed ID: 18553315
[TBL] [Abstract][Full Text] [Related]
10. Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors.
Liebrich M; Guo LH; Schluesener HJ; Schwab JM; Dietz K; Will BE; Meyermann R
Arch Immunol Ther Exp (Warsz); 2007; 55(1):41-7. PubMed ID: 17221335
[TBL] [Abstract][Full Text] [Related]
11. M2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expression in glioma cells.
Zhang L; Xu Y; Sun J; Chen W; Zhao L; Ma C; Wang Q; Sun J; Huang B; Zhang Y; Li X; Qu X
Oncotarget; 2017 Jan; 8(1):819-832. PubMed ID: 27903982
[TBL] [Abstract][Full Text] [Related]
12. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
Gabrovsky N; Georgieva M; Laleva M; Uzunov K; Miloshev G
Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor.
Schittenhelm J; Schwab EI; Sperveslage J; Tatagiba M; Meyermann R; Fend F; Goodman SL; Sipos B
J Neuropathol Exp Neurol; 2013 Mar; 72(3):194-210. PubMed ID: 23399898
[TBL] [Abstract][Full Text] [Related]
14. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
[TBL] [Abstract][Full Text] [Related]
15. The microglial/macrophagic response at the tumour-brain border of invasive meningiomas.
Grund S; Schittenhelm J; Roser F; Tatagiba M; Mawrin C; Kim YJ; Bornemann A
Neuropathol Appl Neurobiol; 2009 Feb; 35(1):82-8. PubMed ID: 19187060
[TBL] [Abstract][Full Text] [Related]
16. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ
Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417
[TBL] [Abstract][Full Text] [Related]
17. Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue.
Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Petersen-Baltussen HM; ter Laan M; Wesseling P; Adema GJ
J Neuropathol Exp Neurol; 2015 May; 74(5):390-400. PubMed ID: 25853692
[TBL] [Abstract][Full Text] [Related]
18. Detection of M2-macrophages in uveal melanoma and relation with survival.
Bronkhorst IH; Ly LV; Jordanova ES; Vrolijk J; Versluis M; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):643-50. PubMed ID: 20811059
[TBL] [Abstract][Full Text] [Related]
19. Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.
Akiyama Y; Komiyama M; Miyata H; Yagoto M; Ashizawa T; Iizuka A; Oshita C; Kume A; Nogami M; Ito I; Watanabe R; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Yamaguchi K
Oncol Rep; 2014 Apr; 31(4):1683-90. PubMed ID: 24573400
[TBL] [Abstract][Full Text] [Related]
20. Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype.
Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Kristensen BW
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):185-206. PubMed ID: 28767130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
